134 related articles for article (PubMed ID: 22104973)
1. Sulfur and selenium derivatives of quinazoline and pyrido[2,3-d]pyrimidine: synthesis and study of their potential cytotoxic activity in vitro.
Moreno E; Plano D; Lamberto I; Font M; Encío I; Palop JA; Sanmartín C
Eur J Med Chem; 2012 Jan; 47(1):283-98. PubMed ID: 22104973
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro anticancer activities of some selenadiazole derivatives.
Plano D; Moreno E; Font M; Encío I; Palop JA; Sanmartín C
Arch Pharm (Weinheim); 2010 Nov; 343(11-12):680-91. PubMed ID: 21110339
[TBL] [Abstract][Full Text] [Related]
3. Substituted thiazoles V. synthesis and antitumor activity of novel thiazolo[2,3-b]quinazoline and pyrido[4,3-d]thiazolo[3,2-a]pyrimidine analogues.
Al-Omary FA; Hassan GS; El-Messery SM; El-Subbagh HI
Eur J Med Chem; 2012 Jan; 47(1):65-72. PubMed ID: 22056277
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamates.
Ibáñez E; Plano D; Font M; Calvo A; Prior C; Palop JA; Sanmartín C
Eur J Med Chem; 2011 Jan; 46(1):265-74. PubMed ID: 21115210
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiproliferative activity of novel methylselenocarbamates.
Romano B; Font M; Encío I; Palop JA; Sanmartín C
Eur J Med Chem; 2014 Aug; 83():674-84. PubMed ID: 25014639
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J
Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165
[TBL] [Abstract][Full Text] [Related]
8. Biological profile of new apoptotic agents based on 2,4-pyrido[2,3-d]pyrimidine derivatives.
Cordeu L; Cubedo E; Bandrés E; Rebollo A; Sáenz X; Chozas H; Victoria Domínguez M; Echeverría M; Mendivil B; Sanmartin C; Palop JA; Font M; García-Foncillas J
Bioorg Med Chem; 2007 Feb; 15(4):1659-69. PubMed ID: 17204425
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study.
El-Azab AS; Al-Omar MA; Abdel-Aziz AA; Abdel-Aziz NI; el-Sayed MA; Aleisa AM; Sayed-Ahmed MM; Abdel-Hamide SG
Eur J Med Chem; 2010 Sep; 45(9):4188-98. PubMed ID: 20599299
[TBL] [Abstract][Full Text] [Related]
10. In vitro radical scavenging and cytotoxic activities of novel hybrid selenocarbamates.
Romano B; Plano D; Encío I; Palop JA; Sanmartín C
Bioorg Med Chem; 2015 Apr; 23(8):1716-27. PubMed ID: 25792142
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest.
Fares M; Abou-Seri SM; Abdel-Aziz HA; Abbas SE; Youssef MM; Eladwy RA
Eur J Med Chem; 2014 Aug; 83():155-66. PubMed ID: 24956552
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor.
Smaill JB; Palmer BD; Rewcastle GW; Denny WA; McNamara DJ; Dobrusin EM; Bridges AJ; Zhou H; Showalter HD; Winters RT; Leopold WR; Fry DW; Nelson JM; Slintak V; Elliot WL; Roberts BJ; Vincent PW; Patmore SJ
J Med Chem; 1999 May; 42(10):1803-15. PubMed ID: 10346932
[TBL] [Abstract][Full Text] [Related]
13. Novel selenadiazole derivatives as selective antitumor and radical scavenging agents.
Ruberte AC; Plano D; Encío I; Aydillo C; Sharma AK; Sanmartín C
Eur J Med Chem; 2018 Sep; 157():14-27. PubMed ID: 30071406
[TBL] [Abstract][Full Text] [Related]
14. 8,11-dihydroxy-6-[(aminoalkyl)amino]-7H-benzo[e]perimidin-7-ones with activity in multidrug-resistant cell lines: synthesis and antitumor evaluation.
Stefańska B; Dzieduszycka M; Bontemps-Gracz MM; Borowski E; Martelli S; Supino R; Pratesi G; De Cesare M; Zunino F; Kuśnierczyk H; Radzikowski C
J Med Chem; 1999 Sep; 42(18):3494-501. PubMed ID: 10479282
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxicity of 2-phenylquinazolin-4(3H)-one derivatives.
Rhee HK; Yoo JH; Lee E; Kwon YJ; Seo HR; Lee YS; Choo HY
Eur J Med Chem; 2011 Sep; 46(9):3900-8. PubMed ID: 21704436
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticancer effects of some novel pyrazolo[3,4-d]pyrimidine derivatives by generating reactive oxygen species in human breast adenocarcinoma cells.
Rashad AE; Mahmoud AE; Ali MM
Eur J Med Chem; 2011 Apr; 46(4):1019-26. PubMed ID: 21315495
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of substituted benzylamino- and heterocyclylmethylamino carbodithioate derivatives of 4-(3H)-quinazolinone and their cytotoxic activity.
Cao SL; Feng YP; Zheng XL; Jiang YY; Zhang M; Wang Y; Xu M
Arch Pharm (Weinheim); 2006 May; 339(5):250-4. PubMed ID: 16619282
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative activity of 2,4-disubstituted 6-aryl-7H-pyrrolo[3,2-d]pyrimidin-7-one 5-oxides.
Pudziuvelyte E; Ríos-Luci C; León LG; Cikotiene I; Padrón JM
Bioorg Med Chem; 2009 Jul; 17(14):4955-60. PubMed ID: 19527934
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents.
Rostom SA; Ashour HM; Abd El Razik HA
Arch Pharm (Weinheim); 2009 May; 342(5):299-310. PubMed ID: 19415663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
